TerminatedNot Applicable

The STAR™ Tumor Ablation Registry

Stopped: Difficulty Enrolling

United States65 participantsStarted 2015-10

Plain-language summary

Registry collecting data on use of The STAR™ Tumor Ablation System.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae (T1-L5) that will be treated with t-RFA using the STAR™ Tumor Ablation System. * Have signed informed consent Exclusion Criteria: * Subjects under 18 years old * Subjects with heart pacemakers, or other electronic device implants * Subjects intended for t-RFA in vertebral body levels C1-7

What they're measuring

Pain relief (Numerical Rating Pain Scale), post t-RFA

Timeframe: 1 month

Trial details

NCT IDNCT02419703

SponsorMerit Medical Systems, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-03-20

View on ClinicalTrials.gov More Metastatic Lesions in Vertebral Bodies trials